Ming-Chu Hsu
Direktor/Vorstandsmitglied bei TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Profil
Ming-Chu Hsu is the founder and currently holds the position of Chairman, President & Chief Executive Officer at TaiGen Biotechnology Co., Ltd., which was founded in 2001.
Dr. Hsu is also a Director at TaiGen Biopharmaceuticals Holdings Ltd.
since 2001.
In the past, Dr. Hsu worked as a Research Director at Hoffmann-La Roche, Inc., Director-Biotechnology & Pharmaceutical Research at National Health Research Institutes, Research Fellow at California Institute of Technology, and Assistant Professor at The Rockefeller University.
Dr. Hsu obtained a doctorate degree from the University of Illinois.
Aktive Positionen von Ming-Chu Hsu
| Unternehmen | Position | Beginn |
|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 02.01.2019 |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Vorstandsvorsitzender | 01.01.2001 |
Ehemalige bekannte Positionen von Ming-Chu Hsu
| Unternehmen | Position | Ende |
|---|---|---|
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
| National Health Research Institutes | Corporate Officer/Principal | - |
| The Rockefeller University | Corporate Officer/Principal | - |
Ausbildung von Ming-Chu Hsu
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| National Health Research Institutes |
